Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · IEX Real-Time Price · USD
5.22
+0.02 (0.38%)
Jul 26, 2024, 4:30 PM EDT - Market closed
Applied Therapeutics Revenue
Applied Therapeutics had revenue of $190.00K in the quarter ending March 31, 2024, a decrease of -98.22%. This brings the company's revenue in the last twelve months to $-477.00K, down -104.47% year-over-year. In the year 2023, Applied Therapeutics had annual revenue of $9.99M.
Revenue (ttm)
$-477.00K
Revenue Growth
-104.47%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
25
Market Cap
596.47M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Varex Imaging | 855.80M |
ZimVie | 350.20M |
National Research | 147.42M |
Surmodics | 142.96M |
Quanterix | 125.98M |
IRadimed | 67.69M |
APLT News
- 26 days ago - Applied Therapeutics Added to Russell 3000® Index - GlobeNewsWire
- 6 weeks ago - Top 4 Health Care Stocks That May Keep You Up At Night This Month - Benzinga
- 2 months ago - Applied Therapeutics Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer - GlobeNewsWire
- 4 months ago - US FDA extends review of Applied Therapeutics' genetic disease drug - Reuters
- 4 months ago - Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia - GlobeNewsWire
- 5 months ago - Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results - GlobeNewsWire
- 5 months ago - Applied Therapeutics Announces $100 Million Private Placement - GlobeNewsWire